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Neuropsychopharmacology research is between a rock and a hard place. The rock is 
the historical, but slow, hypothesis-driven approach, where discovery occurs by 
testing candidate mechanisms in already well-known biological models. The hard 
place is the innovative, but overwhelming, hypothesis-free approach, where ‘omics’ 
analyses of everything that is analysable generates a deluge of data implicating 
hitherto unknown mechanisms. So, either we have little data on things we already 
know, or too much data and cannot find the needle in a haystack. One solution is to 
mix apples and oranges: integrating cross-species and cross-tissues ‘omics’ data to 
find mechanisms that recur across different experimental and clinical models. The 
idea has been used with remarkable success. And yes, we will finish with the 
proverbs now. 
 Niculescu et al. (2000) first developed and used such an approach, which they called 
Convergent Functional Genomics. More recently, the approach has been used by 
them to help prioritize genes from GWAS of bipolar disorder (Patel et al. 2010), 
integrating GWAS findings, transcriptomics data on postmortem human brain and 
blood, and studies in animal models, in order to identify top-genes supported by all 
approaches. They identified six genes (ARNTL, MBP, BDNF, NRG1, RORB and 
DISC1) which are involved in relevant biological processes, such as circadian 
rhythm, connectivity and neuroplasticity. They used a similar strategy for 
schizophrenia (Ayalew et al., 2012). Interestingly, this strategy could be done with 
publically available data rather than being based on novel experimental findings.  
 
In 2013, we studied transcriptomics data from the hippocampus of adult prenatally 
stressed rats (an established animal model of depression with high glucocorticoid 
levels) and from a human neuronal stem cell line (that we treated with a 
concentration of cortisol that reduces neurogenesis) (Anacker et al., 2013). We 
found that TGFβ-SMAD2/3 and Hedgehog signaling are reduced in both models: 
TGFβ-SMAD2/3 promotes neurogenesis (and has been found to be reduced in 
depressed patients), while Hedgehog promotes neuronal differentiation (and has not 
been studied in depressed patients yet). Similarly, Malki et al. (2016) studied 
transcriptomics from the prefrontal cortex of mice bred for high aggressive behavior 
and from the brain of zebrafish exposed to aggressive social encounters. They 
identified seven genes shared in both datasets, including HDAC4, which has genetic 
variants associated with aggressive behavior in mental retardation, and it is targeted 
by valproic acid, a pharmacological treatment for aggressive behavior. Finally, Luoni 
et al. (2016) studied methylome analyses performed in multiple models of early life 
stress: rats exposed to prenatal stress (prefrontal cortex); human newborns exposed 
to stress in pregnancy (cells from the umbilical cord); and rhesus monkeys exposed 
to stressful rearing conditions (peripheral blood and prefrontal cortex). Their top gene 
was Ank3, a gene with a strong association for psychiatric disorders; and they also 
demonstrated an interaction between functional genetic variants within Ank3 gene 
and obstetric complications on working memory in humans. While these studies are 
predominantly ‘comparative’ in their nature, this cross-species and cross-tissues 
approach can be used to produce ‘integrative’ findings when it generates novel lists 
of overlapping or functionally-related genes through statistical or bioinformatic 
analysis.    
 
With the collapse of R&D in mental health by pharmaceutical companies, 
convergent/integrative ‘omics’ approach represents a unique opportunity for the 
scientific community to mine existing datasets as well as data from experimental and 
clinical models, in order to prioritise targets for the psychotropic medications of the 
future. 
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